UBS Group AG - INNOVATE BIOPHARMACEUTICLS I ownership

Back to all holdings Add to watchlist

INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 37 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q2 2018. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
UBS Group AG ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q1 2020$1,000
-83.3%
1,705
-83.3%
0.00%–
Q4 2019$6,000–10,192
+16608.2%
0.00%–
Q2 2019$0
-100.0%
61
-99.6%
0.00%–
Q4 2018$32,000
+357.1%
13,791
+1279.1%
0.00%–
Q3 2018$7,000
-96.1%
1,000
-86.9%
0.00%–
Q2 2018$179,000–7,615–0.00%–
 Download
Other shareholders
INNOVATE BIOPHARMACEUTICLS I shareholders Q2 2018
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders